Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/9/2026

Anesthesia Considerations in Pregnancy

Intravenous Anesthetic Agents

  • The American Society of Anesthesiologists recommends that ketamine should be avoided when possible as it crosses the placenta and may cause neuronal apoptosis in the developing fetal brain 1
  • Etomidate is preferred over ketamine but should still be used with caution, according to the American College of Obstetricians and Gynecologists 2
  • Thiopental can be used but with careful consideration of maternal and fetal effects, as suggested by the American Society of Anesthesiologists 2

Neuromuscular Blocking Agents

  • The American College of Obstetricians and Gynecologists recommends that cisatracurium and rocuronium are the only FDA pregnancy category B neuromuscular blocking agents and are preferred in pregnant patients 1
  • Vecuronium, atracurium, and pancuronium are pregnancy class C drugs and should be avoided for long-term infusion, especially in the first trimester, according to the American Society of Anesthesiologists 1
  • All neuromuscular blocking agents except cisatracurium cross the placental barrier, which should be considered when selecting an agent, as noted by the American College of Obstetricians and Gynecologists 1

Sedatives and Anxiolytics

  • The American College of Obstetricians and Gynecologists recommends that benzodiazepines should be avoided, especially diazepam, which has an active metabolite with prolonged half-life 2, 3
  • Midazolam is preferred over diazepam due to shorter half-life, but should still be used with caution, according to the American Society of Anesthesiologists 3
  • Dexmedetomidine has limited data in pregnancy; use with caution, as suggested by the American College of Obstetricians and Gynecologists 3

Opioid Analgesics

  • Oxycodone should be avoided due to higher risk of sedation compared to other opioids, according to the American Pain Society 4
  • Tramadol should be used with caution and close monitoring, as recommended by the American Society of Anesthesiologists 4
  • Remifentanil is preferred if opioid analgesia is necessary due to short context-sensitive half-life, according to the American College of Obstetricians and Gynecologists 4

Pitfalls to Avoid

  • Never discontinue neuromuscular blocking agents abruptly prior to clinical determination of brain death, as recommended by the American Society of Anesthesiologists 1
  • Aspirin should be avoided in analgesic doses during pregnancy, according to the American College of Obstetricians and Gynecologists 3

Guideline Summary for Remifentanil‑Propofol Use in Cesarean Section

Pharmacologic Compatibility and Breastfeeding

  • Propofol is fully compatible with obstetric anesthesia, exhibiting minimal transfer to breast milk (≈0.025 %) and requiring no waiting period before the mother resumes breastfeeding. 5
  • Both propofol and remifentanil are compatible with breastfeeding; no waiting period is needed after a single‑dose or short‑duration infusion. 5
  • Multimodal postoperative analgesia that includes paracetamol and NSAIDs is safe for breastfeeding mothers and should be initiated early. 5

Neonatal Safety

  • Neonatal resuscitation equipment must be immediately available for any general anesthetic performed for cesarean delivery. 5

Hemodynamic and Respiratory Safety

  • Targeting a low remifentanil effect‑site concentration (0.5 ng/mL, the lower end of the clinical range) minimizes hypotensive effects while still providing adequate analgesia. 6
  • High‑dose remifentanil boluses (>2 µg/kg) can cause prolonged apnea (up to ~13 minutes) and severe hypotension without improving intubation conditions; such doses should be avoided. 6
  • Adding propofol to remifentanil markedly increases the risk of respiratory depression (bradypnea, desaturation < 90 %, apnea), necessitating immediate airway control and continuous monitoring. 6

Post‑operative Analgesia Planning

  • Because remifentanil provides no postoperative analgesia, a longer‑acting opioid (e.g., morphine 0.1–0.15 mg/kg IV or intrathecal morphine 100–200 µg) should be administered before discontinuing the remifentanil infusion to prevent an analgesic gap. [7][8]